Biopharma Supply Chain Conference 2026 to Feature Site Visit to Shanghai Cellular Therapy Group Co., Ltd.

(Source: Medical Logistics and Supply Chain Branch of China Federation of Logistics and Purchasing)

May 21-23, "2026 Biomedical Supply Chain Conference and the 15th Pharmaceutical Cold Chain Meeting" will be held in Shanghai. On May 23, the organizer will arrange for attendees to visitShanghai Cell Therapy Group Co., Ltd.Visit and inspection, everyone is welcome to sign up actively! Contact for registration: Chang Yang 18610639524

About

Shanghai Cell Therapy Group

Hot

Shanghai Cell Therapy Group, established in 2013, is the first and only company in China that covers the entire value chain of cell-based healthcare. Headquartered at No. 1535 Yuanguo Road, Jiading District, Shanghai, the company occupies an area of 55 mu, with a total construction area of 16,237 square meters for its Phase II Cell Preparation Center/Comprehensive Repository. The group's mission is to "enable cells to extend and enrich the length of life," focusing on cellular rejuvenation as its core. It concentrates on three major initiatives: Baize (tumor immunotherapy), Jiliang (anti-aging), and Chenghuang (regeneration).Build a full closed-loop industry chain for adult immune cell and stem cell storage, cell drug R&D, genetic testing, cancer prevention, postoperative cancer recurrence prevention, CAR-T cell therapy, and cell recharging. Possessing independent core technologies such as JL-Flash CAR-T, nanobody-armored CAR-T, DC vaccines, gene writing, and over 600 patents. Platforms include the Mengchao Cancer Hospital affiliated with Shanghai University, the Shanghai Cell Preservation Bank, and the Baize Testing Institute. Industrial centers are located in Shanghai, Beijing, Henan, Zhejiang, Hainan, the United States, and other regions. Committed to making advanced and affordable cell therapies accessible to the public, with the goal of achieving a 60% tumor regression rate and reaching 60% of the population for a longevity revolution.

With industry centers located in Shanghai, Beijing, Henan, Zhejiang, Hainan, the United States, and other regions, it has ranked first in the industry for three consecutive years in terms of cell storage growth and market share. Trusted by over 100,000 clients, it has provided health management services to more than 20,000 families. It has been recognized as a "National High-tech Enterprise" for 10 consecutive years and has received blessings, academic exchanges, and support from 82 Nobel laureates.

Qualifications & Honors and Industry Status

As the industry leader, it has received numerous honors.

Shanghai Cell Therapy Group is a high-tech company established on the basis of a municipal engineering technology research center approved by the Shanghai Science and Technology Commission. Since its inception, it has received numerous honors and advanced titles.

Nobel Center

Contact Us

During the same period, the "2026 Biopharmaceutical Supply Chain Conference and the 15th Pharmaceutical Cold Chain Meeting" will be held in Shanghai.

Click to View the Latest Schedule▼

May 21-23, Shanghai: Discussing New Directions in the Transformation of the Biomedical Industry and Supply Chain Collaboration.